Thermo Fisher Scientific stock

TMO · NYSE · USD

$700.22Change from previous close: +0.11%Absolute change: +$0.78

Close · November 13, 2026

Price history

+20.70% over the period

1 year: from $580.13 (November 13, 2025) to $700.22 (November 13, 2026), +20.70%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 13, 2026$700.22
October 30, 2026$697.00
September 30, 2026$675.05
August 31, 2026$617.10
July 31, 2026$574.30
June 30, 2026$501.36
May 29, 2026$492.51
April 30, 2026$478.96
March 31, 2026$491.53
February 27, 2026$521.11
January 30, 2026$578.61
December 31, 2025$579.45
November 28, 2025$590.83
November 13, 2025$580.13

At a glance

TickerLandia's take on Thermo Fisher Scientific

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$435.27
52-wk high$727.56

−3.76% from the 52-week high

Analysts · 27 analysts

Average target$756.52+8.04% vs. price

Buy 23 · Hold 3 · Sell 1 · Strong buy

TickerLandia Fingerprint: Thermo Fisher Scientific

Compared with similar companies: very strong momentum.

Financials and price compared with 27 companies in the diagnostics & research industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Thermo Fisher Scientific is pricier than in the past and in line with similar companies

On the latest fiscal year's earnings (2025), Thermo Fisher Scientific's P/E today is 39.5, above the median of its last 10 fiscal years (32.1; between 27.7 and 35.4 from 2016 to 2025). Thermo Fisher Scientific's P/E (trailing 12 months): 36.9, in line with the median of a group of 10 similar companies (36.5).

P/E compared with its history

Compared with 10 similar companies

Thermo Fisher Scientific's metrics compared with similar companies
MetricThermo Fisher ScientificPosition in the groupBand
P/E (trailing 12 months)36.9Middle
Forward P/E25.2Middle
Operating margin19.1%Middle
ROE13.4%Middle
Debt/equity0.75Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Thermo Fisher Scientific. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$12.14B

Latest quarter · Q3 2026

Net income

$1.72B

Latest quarter · Q3 2026

Quarterly net margin

14.2%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$259.44B
P/E
36.9
EPS
$18.96
Volume
1.83M
Daily trading
€1.41B
Dividend yield
0.26%

How Thermo Fisher Scientific is changing

All results
  • Revenue grew 6.7% a year on average over the last 5 years

  • Operating margin fell from 18.7% to 17.4%

  • Profits turn into cash: free cash flow equal to 108% of net income

Returns

Thermo Fisher Scientific returns with dividends

$1,000 invested in Thermo Fisher Scientific 5 years ago, on November 15, 2021, would be worth $1,123 today with dividends reinvested: +12.32% in total, +2.35% per year. On price alone it would be $1,107 (+10.73%).

PeriodThermo Fisher ScientificS&P 500$1,000 becomes
1 month+5.61%−3.12%$1,056
6 months+56.99%+1.58%$1,570
Year to date+20.84%+10.46%$1,208
1 year+21.12%+12.23%$1,211
3 years+58.83%+71.41%$1,588
5 years+12.32%+61.48%$1,123
10 years+386.61%+249.40%$4,866

Over the last 6 months it has done better than 91% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Thermo Fisher Scientific: technical analysis

Thermo Fisher Scientific is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 3.0% below its highest close since January 2, 1990 ($721.63, November 9, 2026).

Trend
Upward
RSI (14 sessions)
54
Between 30 and 70
vs 200-session average
+26.08%

Support and resistance

Price areas where Thermo Fisher Scientific has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price$700.22
  3. Support$645.49−7.82%2 touches, last on August 25, 2026
  4. Support$631.70−9.79%2 touches, last on October 8, 2026
  5. Support$589.42−15.82%4 touches, last on September 10, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.71
Volatility (60 sessions, annualised)
27.7%
Largest fall in the last year
−31.45%

Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Thermo Fisher Scientific: seasonality

Average monthly price change over 37 years

+2.3%Jan−1.5%Feb+1.3%Mar+2.2%Apr+2.3%May−0.7%Jun+2.0%Jul+0.5%Aug−0.1%Sep+2.3%Oct+2.2%Nov+2.8%Dec

Over the last 37 years, the strongest month for Thermo Fisher Scientific has been December: +2.76% on average, positive in 24 years out of 36. The weakest has been February: −1.45% on average, positive in 18 years out of 37. November, the current month, has been positive in 20 years out of 36 (+2.21% on average).

Show chart data
MonthAverageMedianPositive years
January+2.33%+2.74%20 of 36
February−1.45%−0.36%18 of 37
March+1.33%+1.40%21 of 37
April+2.17%+1.36%22 of 37
May+2.32%+2.65%23 of 37
June−0.73%−0.54%15 of 37
July+2.02%+3.54%25 of 37
August+0.49%+1.95%23 of 37
September−0.07%+1.24%23 of 37
October+2.34%+2.45%24 of 37
November+2.21%+2.44%20 of 36
December+2.76%+1.48%24 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Thermo Fisher Scientific and its competitors

Pharmaceutical and biotechnology companies, academic and government laboratories, clinical laboratories, environmental and industrial users, and hospitals make up the customer base of this group, which sells in markets around the world. Its offering spans reagents, instruments and consumables used in biological and medical research, tools for the discovery and production of drugs and vaccines, and diagnostics for infections and diseases.

Headquarters
Waltham, United States
Employees
125,000
Founded
1956
Chief executive
Marc Casper
Thermo Fisher Scientific and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Thermo Fisher ScientificTMO$259.44B19.1%36.9+56.99%
DanaherDHR$163.94B22.0%38.6+40.38%
WatersWAT$90.45B16.0%192.6+37.42%
IDEXX LaboratoriesIDXX$55.48B32.5%47.0+33.21%
Agilent TechnologiesA$49.04B24.5%34.3+54.30%
NateraNTRA$46.27B-8.5%—+63.37%

Same industry or related industries, similar size. Compare Thermo Fisher Scientific with its competitors · Full profile